Key Points – Cronos Group posted record Q1 2026 results, with consolidated net revenue of CAD 45.2 million, up 40% year over year, and adjusted EBITDA rising to CAD 5.1 million.
Gross profit also improved, helped by stronger sales volumes and higher prices, especially in international markets. – Israel and other overseas markets were the main growth engines, with Cronos Israel delivering its ninth straight record quarter and international revenue up 97% year over year
Management said Peace Naturals, LIT and the newly launched Lord Jones are strengthening the company’s position abroad. – In Canada, Spinach and other brands gained meaningful share, including Spinach becoming the No. 1 vape brand and Cronos holding the top edible position. The company also ended the quarter with CAD 822 million in cash and no debt, and its board approved a new CAD 50 million share buyback program. – Cannabis: One Stock to Play the Movement Cronos Group (NASDAQ:CRON) reported record first-quarter 2026 net revenue and gross profit, with management pointing to growth in Israel, gains for its Spinach brand in Canada and continued international expansion as key drivers of the quarter. Chairman, President and CEO Mike Gorenstein said Cronos “delivered record net revenue and gross profit in Q1 2026” as the company continued to execute on its strategic plan.
He highlighted record net revenue from international markets and market share gains for Canadian brands, including Spinach reaching the No. 1 market share position in vapes. – Will This New Development Mean A Big Rally In Cannabis Stocks? CFO Anna Shlimak said consolidated net revenue totaled CAD 45.2 million, up 40% year over year. She attributed the increase to higher cannabis flower sales in Israel, Canada and other countries, along with higher cannabis extract sales in Canada.